Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer progression and patient health. Stage 1 focuses on tumor removal, Stage 2 ...
Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, ...
Racial disparities in molecularly targeted trials of tyrosine kinase inhibitors (TKI) for the perioperative management of oncogene-driven non-small cell lung cancer (NSCLC): A systematic review. This ...
C5aR1 expression correlates with increased metastasis risk and poor survival in cSCC patients. The tumor microenvironment, especially fibroblasts, influences C5aR1 expression and cSCC progression.
Abbreviations: 2D, two dimensional radiotherapy; 3D, three dimensional radiotherapy; CRT, chemoradiation; IMRT, intensity-modulated radiotherapy; RT, radiotherapy; VMAT, volumetric modulated arc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results